Profil
Dr. Shuli Kulak is a Head-Corporate Strategy & Business Development at Solid Biosciences, Inc. Dr. Kulak was previously employed as a Head-Corporate Strategy & Business Development by AavantiBio, Inc. She received her MBA from Sy Syms School of Business and a doctorate degree from Albert Einstein College of Medicine, Inc..
Aktive Positionen von Shuli Kulak
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLID BIOSCIENCES INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Shuli Kulak
| Unternehmen | Position | Ende |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Corporate Officer/Principal | - |
Ausbildung von Shuli Kulak
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sy Syms School of Business
Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
















